Management of orocutaneous fistulas using a vacuum-assisted closure system.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23733717.
- Also identified by DOI 10.1002/hed.23393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The vacuum-assisted closure (VAC) system has been used to manage complicated wounds. The purpose of this study was to describe a novel technique in using the VAC system for orocutaneous fistulas. A retrospective study was performed on 10 patients treated at the National Cancer Centre, Singapore, who developed postoperative orocutaneous fistulas. Hydrogum dental paste was used as a sealant together with the VAC system to close the fistulas. We used either the RENASYS or VAC ATS system with 50 mm Hg to 125 mm Hg continuous suction. The 10 patients developed 11 fistulas. The median age of this cohort was 67 years (range, 33-80 years). Nine patients had successful closure of their fistulas with VAC therapy whereas 1 patient had unsuccessful VAC therapy and required flap reconstruction. The median time to fistula closure was 19 days (range, 6-36 days). The median time to radiotherapy after surgery was 46 days (range, 26-62 days). VAC therapy is an effective treatment option for orocutaneous fistulas.
Medical subject headings
- Cutaneous Fistula
- Dental Cements
- Negative-Pressure Wound Therapy
- Oral Fistula